458 related articles for article (PubMed ID: 18617469)
41. A multiinstitutional survey of the Wiskott-Aldrich syndrome.
Sullivan KE; Mullen CA; Blaese RM; Winkelstein JA
J Pediatr; 1994 Dec; 125(6 Pt 1):876-85. PubMed ID: 7996359
[TBL] [Abstract][Full Text] [Related]
42. A Clinical Diagnosis of Wiskott Aldrich Syndrome in an Ethiopian Boy with Recurrent Sinopulmonary Infections: A Case Report.
Deribssa SJ; Alemayehu T
Ethiop J Health Sci; 2020 Nov; 30(6):1051-1054. PubMed ID: 33883853
[TBL] [Abstract][Full Text] [Related]
43. [Wiskott-Aldrich syndrome with platelets of normal size and c.295C>T mutation of the WAS gene. Case report].
Cunha-Carneiro ML; Xavier-Andrade M; Bacarini-Leite LF; Mosca T; Carvalho Neves Forte W
Rev Alerg Mex; 2023 Apr; 69(4):228-231. PubMed ID: 37218050
[TBL] [Abstract][Full Text] [Related]
44. Report of clinical presentations and two novel mutations in patients with Wiskott-Aldrich syndrome/X-linked Thrombocytopenia.
Udomkittivorakul N; Wattanasirichaigoon D; Manuyakorn W; Pongphitcha P; Khongkraparn A; Tunlayadechanont P; Sirachainan N
Platelets; 2022 Jul; 33(5):792-796. PubMed ID: 34705590
[TBL] [Abstract][Full Text] [Related]
45. Wiskott-Aldrich syndrome with macrothrombocytopenia.
Skoric D; Dimitrijevic A; Cuturilo G; Ivanovski P
Indian Pediatr; 2014 Dec; 51(12):1015-6. PubMed ID: 25560165
[TBL] [Abstract][Full Text] [Related]
46. A novel mutation in Wiskott-Aldrich gene manifesting as macrothrombocytopenia and neutropenia.
Arwani M; Lee D; Haddad A; Mewawalla P
BMJ Case Rep; 2018 Jul; 2018():. PubMed ID: 29991546
[TBL] [Abstract][Full Text] [Related]
47. Linking cellular activation to cytoskeletal reorganization: Wiskott-Aldrich syndrome as a model.
Stewart DM; Tian L; Nelson DL
Curr Opin Allergy Clin Immunol; 2001 Dec; 1(6):525-33. PubMed ID: 11964736
[TBL] [Abstract][Full Text] [Related]
48. Wiskott-Aldrich syndrome.
Notarangelo LD; Miao CH; Ochs HD
Curr Opin Hematol; 2008 Jan; 15(1):30-6. PubMed ID: 18043243
[TBL] [Abstract][Full Text] [Related]
49. Autonomous role of Wiskott-Aldrich syndrome platelet deficiency in inducing autoimmunity and inflammation.
Sereni L; Castiello MC; Marangoni F; Anselmo A; di Silvestre D; Motta S; Draghici E; Mantero S; Thrasher AJ; Giliani S; Aiuti A; Mauri P; Notarangelo LD; Bosticardo M; Villa A
J Allergy Clin Immunol; 2018 Oct; 142(4):1272-1284. PubMed ID: 29421274
[TBL] [Abstract][Full Text] [Related]
50. [Wiskott-Aldrich syndrome in a hetrozygous woman].
Tornai I; Kiss A; Laczkó J; Nagy PM
Orv Hetil; 1989 Mar; 130(13):679-82. PubMed ID: 2657554
[TBL] [Abstract][Full Text] [Related]
51. Characterization of the Wiskott-Aldrich syndrome protein and its role in the disease.
Nonoyama S; Ochs HD
Curr Opin Immunol; 1998 Aug; 10(4):407-12. PubMed ID: 9722916
[TBL] [Abstract][Full Text] [Related]
52. Molecular characterization of two Malaysian patients with Wiskott-Aldrich syndrome.
Baharin MF; Kader Ibrahim SB; Yap SH; Abdul Manaf AM; Mat Ripen A; Dhaliwal JS
Malays J Pathol; 2015 Aug; 37(2):153-8. PubMed ID: 26277674
[TBL] [Abstract][Full Text] [Related]
53. Identification of a novel WAS mutation in a South African patient presenting with atypical Wiskott-Aldrich syndrome: a case report.
Glanzmann B; Möller M; Schoeman M; Urban M; van Helden PD; Frigati L; Grewal R; Pieters H; Loos B; Hoal EG; Glashoff RH; Cornelissen H; Rabie H; Esser MM; Kinnear CJ
BMC Med Genet; 2020 Jun; 21(1):124. PubMed ID: 32503528
[TBL] [Abstract][Full Text] [Related]
54. Wiskott Aldrich syndrome: a treatable immune disorder. A review.
Millikan LE
Mo Med; 1973 Nov; 70(11):764-7 passim. PubMed ID: 4591682
[No Abstract] [Full Text] [Related]
55. Wiskott-Aldrich syndrome: a comprehensive review.
Massaad MJ; Ramesh N; Geha RS
Ann N Y Acad Sci; 2013 May; 1285():26-43. PubMed ID: 23527602
[TBL] [Abstract][Full Text] [Related]
56. A novel mutation W252X in the WAS gene in a Korean patient with Wiskott-Aldrich syndrome.
Kim HJ; Yoo EH; Ki CS; Yoo GH; Koo HH; Kim JW; Kim SH
Int J Hematol; 2006 Jun; 83(5):426-8. PubMed ID: 16787874
[TBL] [Abstract][Full Text] [Related]
57. B-cell reconstitution after lentiviral vector-mediated gene therapy in patients with Wiskott-Aldrich syndrome.
Castiello MC; Scaramuzza S; Pala F; Ferrua F; Uva P; Brigida I; Sereni L; van der Burg M; Ottaviano G; Albert MH; Grazia Roncarolo M; Naldini L; Aiuti A; Villa A; Bosticardo M
J Allergy Clin Immunol; 2015 Sep; 136(3):692-702.e2. PubMed ID: 25792466
[TBL] [Abstract][Full Text] [Related]
58. Wiskott-Aldrich syndrome presenting with a clinical picture mimicking juvenile myelomonocytic leukaemia.
Yoshimi A; Kamachi Y; Imai K; Watanabe N; Nakadate H; Kanazawa T; Ozono S; Kobayashi R; Yoshida M; Kobayashi C; Hama A; Muramatsu H; Sasahara Y; Jakob M; Morio T; Ehl S; Manabe A; Niemeyer C; Kojima S
Pediatr Blood Cancer; 2013 May; 60(5):836-41. PubMed ID: 23023736
[TBL] [Abstract][Full Text] [Related]
59. Wiskott-Aldrich Syndrome in four male siblings from a consanguineous family from Lebanon.
Mansour R; El-Orfali Y; Saber A; Noun D; Youssef N; Youssef Y; Hanna-Wakim R; Dbaibo G; Abboud M; Massaad MJ
Clin Immunol; 2020 Oct; 219():108573. PubMed ID: 32814211
[TBL] [Abstract][Full Text] [Related]
60. Clinical aspects and molecular analysis of Chinese patients with Wiskott-Aldrich syndrome in Taiwan.
Lee WI; Yang CY; Jaing TH; Huang JL; Chien YH; Chang KW
Int Arch Allergy Immunol; 2008; 145(1):15-23. PubMed ID: 17703096
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
